KIRKLAND, Wash.--(BUSINESS WIRE)--Cardiac Dimensions®, Inc. today announced that on January 26th it received the CE Mark approval for its CARILLON™ Mitral Contour System™ from KEMA Quality B.V. — a European Union Notified Body from the Netherlands. The CARILLON™ system is a percutaneous treatment for functional mitral regurgitation (FMR). The CE Mark approval is an important milestone for Cardiac Dimensions, allowing the company to market the product in countries that accept CE Marking — primarily Europe. Cardiac Dimensions is now developing plans for commercialization in Europe.
